CN104606670A - Medicine for treating cardiovascular disease - Google Patents
Medicine for treating cardiovascular disease Download PDFInfo
- Publication number
- CN104606670A CN104606670A CN201510035399.1A CN201510035399A CN104606670A CN 104606670 A CN104606670 A CN 104606670A CN 201510035399 A CN201510035399 A CN 201510035399A CN 104606670 A CN104606670 A CN 104606670A
- Authority
- CN
- China
- Prior art keywords
- medicine
- crocodile
- poria
- semen persicae
- cortex cinnamomi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention belongs to the technical field of biological medicines, and in particular relates to a medicine for treating biological medicine. The medicine can effectively treat vessel blockages and cardiovascular disease. According to the technical scheme, the medicine for treating cardiovascular disease is prepared from the following components in percentage by weight: 1 to 25% of crocodile hemoglobin peptide, 5 to 40% of peach kernels, 10 to 30% of poria cocos, 10 to 35% of allium macrostemon, and 1 to 10% of cinnamon. The medicine has the benefits that hemoglobin is extracted from crocodile blood and is mixed with peach kernels, poria cocos, allium macrostemon and cinnamon to prepare the novel medicine which can obviously reduce cardiovascular disease and has extremely small side effect.
Description
Technical field
The invention belongs to biomedicine technical field, particularly relate to a kind of medicine of Cardiovarscular.
Background technology
Current clinical treatment cardiovascular and cerebrovascular disease adopts vasodilation class Western medicine mostly, the rapid expansion of blood vessel can be realized after this kind of drug use, thus make the unobstructed blood vessel of blocking at short notice, thus avoid patient and cause because of blood vessel blockage blood pressure to raise, even bring out the generation of the serious illness such as heart infarction cerebral infarction, its advantage is instant effect, and first aid effect is remarkable clinically.
And the shortcoming of western medicine cardiovascular and cerebrovascular disease be not from patient morbidity root---the basic reason of blood vessel blockage is set about, its result necessarily interim first aid is useful, does not have how long the state of an illness will be shown effect again; And life-time service expansion class medicine, drug residue in patient's blood vessel can be caused to get more and more, and poisonous side effect of medicine worsens increasingly, and blood vessel hardens gradually, and increase the danger that angiorrhexis brings out apoplexy, toxic and side effects is clearly.
Because, develop a kind of can fundamentally treat blood vessel blockage, treatment cardiovascular diseases medicine for be badly in need of.
Summary of the invention
Technical problem to be solved by this invention is to provide the medicine of a kind of effective treatment blood vessel blockage, Cardiovarscular.
In order to solve the problem, technical scheme provided by the present invention is:
A kind of medicine of Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, the percentage by weight of described each component is: crocodile hemoglobin peptide: 1% to 25%, Semen Persicae 5% to 40%, Poria 10% to 30%, Bulbus Allii Macrostemonis 10% to 35%, Cortex Cinnamomi 1% to 10%.
Preferably, the percentage by weight of described each component is: crocodile hemoglobin peptide: 19% to 25%, Semen Persicae 30% to 37%, Poria 26% to 30%, Bulbus Allii Macrostemonis 10% to 14%, Cortex Cinnamomi 1% to 8%.
Preferably, the percentage by weight of described each component is: crocodile hemoglobin peptide: 12% to 25%, Semen Persicae 5% to 33%, Poria 15% to 25%, Bulbus Allii Macrostemonis 29% to 35%, Cortex Cinnamomi 8% to 10%.
Preferably, the percentage by weight of described each component is: crocodile hemoglobin peptide: 8% to 23%, Semen Persicae 10% to 27%, Poria 23% to 30%, Bulbus Allii Macrostemonis 25% to 33%, Cortex Cinnamomi 6% to 10%.
Beneficial effect of the present invention is: the present invention by extracting Hemoglobin Peptide from the blood of crocodile, and be equipped with Semen Persicae, Poria, Bulbus Allii Macrostemonis and Cortex Cinnamomi, making one significantly can improve cardiovascular and cerebrovascular disease, the Novel medicine that side effect is simultaneously extremely low again.
Oxygen molecule entrained by crocodile blood is more than 100 times of the mankind, this superpower oxygen carrying capacity, come from crocodile hemoglobin the peptide chain structure that there is a kind of uniqueness, if this peptide chain is absorbed by the body, can combine with the erythrocyte of human body, form a kind of mixing hemoglobin, thus significantly improve the oxygen content of blood of human body.The present invention is exactly this new approach of oxygen content of blood by improving human body, reduces the hyperlipidemia of human body, hyperglycemia and hypertension.The present invention thus with this Hemoglobin Peptide that extracts in body, first time achieves the oxygen content being improved blood of human body by oral a kind of food, thus blood sugar lowering blood fat reducing very safely, and antithrombotic, and finally eliminating hypertensive arch-criminal from source---blood vessel blockage is a kind of creationary thinking and countermeasure to improving cardiovascular and cerebrovascular disease.
Ask when the ethyl acetate of Semen Persicae and ethanol extraction all can shorten the breathing dyspnea with rapid and short breath that pulmonary infarction caused by platelet aggregation that adenosine diphosphate (ADP) (ADP) induces causes, and ethyl acetate extract has significant anti thrombotic action.Semen Persicae ligroin extraction may be improved effect to treating myocardial ischemia damage, and has good preventive and therapeutic effect to acute myocardial infarction.In addition, the glycerol trioleate be separated from Semen Persicae has anticoagulant active.And the effect such as the anticoagulation of Semen Persicae, antithrombotic, prevention hepatic fibrosis, the protective action good to liver peroxide injury tool, effect is improved to treating myocardial ischemia damage and cerebral vessels activity, have good preventive and therapeutic effect to acute myocardial infarction, this has confirmed blood circulation promoting and blood stasis dispelling tradition effect of Semen Persicae to a certain extent.
Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect.Poria is containing pachyman, glucose, protein, aminoacid, organic acid, fat, lecithin, adenine, choline, ergosterol, multiple enzyme and potassium salt.Energy enhancing human body immunity function, pachyman has obvious antitumor action; There is diuresis, the electrolytical discharge such as potassium, sodium, chlorine in urine can be increased; There is the effect such as generation, blood sugar lowering, anti-radiation of calmness and the liver protecting, suppression ulcer.
Bulbus Allii Macrostemonis can make eater PGE1 content obviously raise, and PGE1 can make platelet adenosine Cyclase Activity strengthen, and increases cAMP endogenous levels, and platelet can be suppressed to synthesize TXA2, and anticoagulant, has effect of good control thrombotic blood vessels disease.
Cortex Cinnamomi decoct can make anesthetized dog arteria coronaria, cerebral blood flow increase, and vascular resistance declines.
Detailed description of the invention
In order to clearer, complete description content of the present invention, provide optimum embodiment to illustrate that the present invention conceives below.Certainly, the embodiment that provides is intended to design of the present invention is described, is not the whole of design of the present invention, more should not be considered as the limitation of design content of the present invention.Under the enlightenment of provided embodiment, done any scheme all belongs to protection scope of the present invention.
Embodiment 1
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 1%, Semen Persicae 35%, Poria 35%, Bulbus Allii Macrostemonis 35%, Cortex Cinnamomi 5%.
Embodiment 2
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 25%, Semen Persicae 30%, Poria 27%, Bulbus Allii Macrostemonis 10%, Cortex Cinnamomi 8%.
Embodiment 3
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 22%, Semen Persicae 34%, Poria 30%, Bulbus Allii Macrostemonis 13%, Cortex Cinnamomi 1%.
Embodiment 4
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 19%, Semen Persicae 37%, Poria 26%, Bulbus Allii Macrostemonis 14%, Cortex Cinnamomi 4%.
Embodiment 5
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 17%, Semen Persicae 40%, Poria 10%, Bulbus Allii Macrostemonis 23%, Cortex Cinnamomi 10%.
Embodiment 6
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 14%, Semen Persicae 33%, Poria 15%, Bulbus Allii Macrostemonis 30%, Cortex Cinnamomi 8%.
Embodiment 7
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 12%, Semen Persicae 29%, Poria 20%, Bulbus Allii Macrostemonis 29%, Cortex Cinnamomi 10%.
Embodiment 8
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 25%, Semen Persicae 5%, Poria 25%, Bulbus Allii Macrostemonis 35%, Cortex Cinnamomi 10%.
Embodiment 9
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 24%, Semen Persicae 15%, Poria 29%, Bulbus Allii Macrostemonis 23%, Cortex Cinnamomi 9%.
Embodiment 10
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 4%, Semen Persicae 36%, Poria 17%, Bulbus Allii Macrostemonis 34%, Cortex Cinnamomi 9%.
Embodiment 11
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 8%, Semen Persicae 27%, Poria 26%, Bulbus Allii Macrostemonis 32%, Cortex Cinnamomi 10%.
Embodiment 12
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 10%, Semen Persicae 25%, Poria 30%, Bulbus Allii Macrostemonis 25%, Cortex Cinnamomi 10%.
Embodiment 13
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 20%, Semen Persicae 20%, Poria 23%, Bulbus Allii Macrostemonis 27%, Cortex Cinnamomi 10%.
Embodiment 14
A medicine for Cardiovarscular, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, and the percentage by weight of described each component is: crocodile hemoglobin peptide: 23%, Semen Persicae 10%, Poria 28%, Bulbus Allii Macrostemonis 33%, Cortex Cinnamomi 6%.
The preparation method of medicine provided by the present invention is:
1), after crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi being carried out ultraviolet sterilization, the abundant mix homogeneously of blender is dropped into;
2) medicine after mixing is contained in tabletting on tablet machine, dries 3 ~ 5 hours at 65-85 DEG C; Take for convenience of patient, also after compression tablet can carry out coating, coating adjuvant and method, identical with method with pharmaceutically conventional adjuvant.
Claims (4)
1. the medicine of a Cardiovarscular, it is characterized in that, described medicine comprises crocodile hemoglobin peptide, Semen Persicae, Poria, Bulbus Allii Macrostemonis, Cortex Cinnamomi, the percentage by weight of described each component is: crocodile hemoglobin peptide: 1% to 25%, Semen Persicae 5% to 40%, Poria 10% to 30%, Bulbus Allii Macrostemonis 10% to 35%, Cortex Cinnamomi 1% to 10%.
2. medicine according to claim 1, is characterized in that: the percentage by weight of described each component is: crocodile hemoglobin peptide: 19% to 25%, Semen Persicae 30% to 37%, Poria 26% to 30%, Bulbus Allii Macrostemonis 10% to 14%, Cortex Cinnamomi 1% to 8%.
3. medicine according to claim 1, is characterized in that: the percentage by weight of described each component is: crocodile hemoglobin peptide: 12% to 25%, Semen Persicae 5% to 33%, Poria 15% to 25%, Bulbus Allii Macrostemonis 29% to 35%, Cortex Cinnamomi 8% to 10%.
4. medicine according to claim 1, is characterized in that: the percentage by weight of described each component is: crocodile hemoglobin peptide: 8% to 23%, Semen Persicae 10% to 27%, Poria 23% to 30%, Bulbus Allii Macrostemonis 25% to 33%, Cortex Cinnamomi 6% to 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510035399.1A CN104606670A (en) | 2015-01-23 | 2015-01-23 | Medicine for treating cardiovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510035399.1A CN104606670A (en) | 2015-01-23 | 2015-01-23 | Medicine for treating cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606670A true CN104606670A (en) | 2015-05-13 |
Family
ID=53141492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510035399.1A Pending CN104606670A (en) | 2015-01-23 | 2015-01-23 | Medicine for treating cardiovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606670A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168255A (en) * | 2015-09-08 | 2015-12-23 | 浙江海洋学院 | Zymolytic tuna blood oral liquid for antithrombotic and thrombolytic therapies and preparation method thereof |
| CN106377685A (en) * | 2016-08-30 | 2017-02-08 | 广州领康科技有限公司 | Peach seed and poria cocos pressed candy for targeted therapy of coronary heart disease and hypertension |
| CN108201602A (en) * | 2016-12-20 | 2018-06-26 | 无限极（中国）有限公司 | A kind of Chinese medicine composition for having effects that assist reducing blood lipid and/or protect blood vessel and preparation method thereof and product |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102512648A (en) * | 2011-12-28 | 2012-06-27 | 张清辉 | Traditional Chinese drug composition for treatment and prevention of metabolic syndrome |
| CN103230587A (en) * | 2013-05-10 | 2013-08-07 | 汪华东 | Composition of crocodile hemoglobin peptide and preparation method of composition |
-
2015
- 2015-01-23 CN CN201510035399.1A patent/CN104606670A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102512648A (en) * | 2011-12-28 | 2012-06-27 | 张清辉 | Traditional Chinese drug composition for treatment and prevention of metabolic syndrome |
| CN103230587A (en) * | 2013-05-10 | 2013-08-07 | 汪华东 | Composition of crocodile hemoglobin peptide and preparation method of composition |
Non-Patent Citations (3)
| Title |
|---|
| 侯如艳: "中医药治疗冠心病临床用药规律研究", 《中国优秀硕士学位论文全文数据库，医药卫生科技辑，广州中医药大学硕士学位论文》 * |
| 李志明: "心律失常现代中医文献的整理与研究", 《中国优秀硕士学位论文全文数据库，医药卫生科技辑，北京中医药大学硕士学位论文》 * |
| 沈会: "心力衰竭古今中医文献的整理与研究", 《中国优秀硕士学位论文全文数据库，医药卫生科技辑，北京中医药大学硕士学位论文》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168255A (en) * | 2015-09-08 | 2015-12-23 | 浙江海洋学院 | Zymolytic tuna blood oral liquid for antithrombotic and thrombolytic therapies and preparation method thereof |
| CN106377685A (en) * | 2016-08-30 | 2017-02-08 | 广州领康科技有限公司 | Peach seed and poria cocos pressed candy for targeted therapy of coronary heart disease and hypertension |
| CN108201602A (en) * | 2016-12-20 | 2018-06-26 | 无限极（中国）有限公司 | A kind of Chinese medicine composition for having effects that assist reducing blood lipid and/or protect blood vessel and preparation method thereof and product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103006730B (en) | Composition containing arginine and panax notoginseng extract for promoting nitric oxide generation and preventing and protecting cardiovascular disease | |
| CN104606670A (en) | Medicine for treating cardiovascular disease | |
| CN107875201A (en) | A kind of anti-trioxypurine intervenes kidney trouble and uremic sea-buckthorn compound preparation and preparation method | |
| CN104921109B (en) | A kind of antisenescence health product and its detection method | |
| CN107753535A (en) | A kind of pharmaceutical composition for treating cardiovascular and cerebrovascular disease and its application | |
| TWI678211B (en) | Uses of cistanche tubulosa extract and isoacteoside in protecting muscles | |
| US11096970B2 (en) | Preparation and application of grain worm for treating diabetes | |
| Chan et al. | Three cases of aconite root poisoning due to Bikhama in a Hong Kong Nepalese family | |
| CN101757443A (en) | Traditional Chinese medicine preparation for treating hemophilia | |
| CN105999246A (en) | Hirudin and dried-leech medicinal liquor and preparation method and application thereof | |
| JP2011012021A (en) | Blood sugar-controlling composition | |
| CN107233481B (en) | A kind of Chinese medicine composition to invigorate the kidney and stop nocturnal emission, medicinal liquor and its preparation method and application | |
| CN1762362A (en) | Medicinal composition with red sage root component for treating cardiovascular and cerebrovascular disease and its application | |
| CN107693682A (en) | A kind of anaesthetic for treating sub- agate disease and preparation method thereof | |
| CN108236623B (en) | Pharmaceutical composition, traditional Chinese medicine oral liquid, traditional Chinese medicine granules and preparation method and application thereof | |
| CN103623258B (en) | One treats anginal pharmaceutical composition and application thereof | |
| Omnia et al. | Biochemical effect of garlic oil administration in heart necrosis induced experimentally in rats | |
| CN102670785B (en) | Preparation method of conventional Chinese medicine composition for treating primary hypertension | |
| US20050208158A1 (en) | Pharmacological composition based on biologically active substances obtained from tribulus terrestris l | |
| TWI701035B (en) | Uses of fu-ling (poria cocos) extract and tumulosic acid in protecting muscles | |
| CN106720841A (en) | A kind of toffee for treating the enlargement of concha chamber and preparation method thereof | |
| CN101081220A (en) | Angiocardiopathy treating traditional Chinese medicine and the preparing technology thereof | |
| CN106562407A (en) | Health-care food with antioxidant function | |
| CN108653491A (en) | A kind of medicine for treating cardiovascular and cerebrovascular disease | |
| CN1557402A (en) | Chinese herbal medicine preparation and its preparing process and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150513 |
|
| RJ01 | Rejection of invention patent application after publication |